Management Team

Edwin R. Thompson:
President

Ed has over 25 years experience in overall pharmaceutical management, sales, marketing, product development, manufacturing, and research and development. He has demonstrated expertise in organizational development and management, as well as product strategic planning for Rx and OTC brands in the United States and Internationally. Prior to founding PMRS in 1994, Ed was President, CEO, and Chairman of the Board at Greenwich Pharmaceuticals, Inc. where he was responsible for the overall performance of the company.

During his seven years at Greenwich, Ed also held positions as President and Chief Operating Officer, as well as Vice President of Marketing and Business Development. Prior to that, he held positions at McNeil Pharmaceutical from 1974 to 1986 as Product Director, Manager of Business Development, District Sales Manager, Anesthesia Sales Representative of Critcon Division, and Territory Sales Representative.

Dennis A. DiBiagio:
Director, Manufacturing Services

A registered pharmacist, Dennis has over 16 years experience in pharmaceutical product development, clinical and commercial manufacturing. He has played key roles in drug development efforts from discovery through phase IV clinical trials. The PMRS facility build-out was completed under his direction including the installation of all key services such as Purified Water, USP system and HVAC systems in compliance with current good manufacturing practice regulations and safety requirements. Dennis joined PMRS in 1994, and is responsible for all aspects of process and product development projects from formulation trials through clinical and commercial scale manufacturing and distribution.

From 1988 to 1994, Dennis held positions at Greenwich Pharmaceuticals, Inc. as Director of Manufacturing, Manager of Product Development - New Molecular Entities, Manager of Research and Development Facility, and Senior Formulation Pharmacist. Prior to that, he was Product Development Pharmacist, Senior Supervisor of Tablet Manufacturing, and Supervisor of Liquid Manufacturing at Rorer Pharmaceuticals, Inc.

Chad J. Beaver:
Director, Quality Management

Chad has over 9 years experience in pharmaceutical quality control and quality assurance. Chad’s laboratory background includes analytical method development and validation, clinical and commercial drug product stability, and in-process and finished product release testing. His quality assurance leadership includes management of regulatory, external and internal audit systems as well as supplier and equipment contractor programs. He has demonstrated experience in quality management systems development, including implementation of quality by design principles through electronic batch records, SOPs, and quality agreements. Chad also has experience in project management of pharmaceutical drug products, facility and process validation and the ISO9001 quality standard. He joined PMRS in 2000, and is responsible for cGMP regulatory compliance, customer satisfaction, Quality and Information Technology. Chad holds a B.S. in Biochemistry and B.A. in Chemistry from Temple University.

James F. Hansell:
Director, Analytical Services

Jim has over 18 years experience in pharmaceutical quality control and analytical method development. His experience includes development and validation of methodology for raw materials, intermediates and finished products in a variety of dosage forms. Jim has extensive experience in the area of drug product and drug substance stability. He joined PMRS in 1995, and is responsible for all analytical service operations including method development, validation and transfer, quality control functions and laboratory compliance to customer, SOP and cGMP requirements. Jim held positions in the analytical labs at both Janssen Research Foundation and McNeil Consumer Products Company before starting at PMRS. Prior to that, Jim held the position of Research Chemist, in which he was responsible for the development, testing and management of the company’s stability program at Greenwich Pharmaceuticals, Inc. He was also Manager, R&D Facility, where he oversaw the stability program at Greenwich Pharmaceuticals, Inc.